Revance

Revance

Biotechnology Research

Nashville, Tennessee 29,676 followers

Über uns

Revance is a biotechnology company setting the new standard in healthcare with innovative aesthetic and therapeutic offerings that elevate patient and physician experiences.

Website
http://www.revance.com
Industrie
Biotechnology Research
Größe des Unternehmens
501-1,000 employees
Hauptsitz
Nashville, Tennessee
Typ
Öffentliches Unternehmen
Spezialitäten
Botulinum Toxin, biotechnology, biotech, healthcare, pharmaceuticals, science, research, financial services, and fintech

Standorte

Employees at Revance

Aktualisierungen

  • View organization page for Revance, graphic

    29,676 followers

    It’s the four-year anniversary of the #RHACollection and we’ve got so many reasons to celebrate! We’ve just hit a major milestone of selling more than ONE MILLION boxes of our award-winning fillers, and we continue to be the fastest growing #HyaluronicAcid filler brand in the US. Thanks a MILLION to our partner practices for embracing innovation and supporting us over the past four years. How are you celebrating RHA®? If you haven’t tried the RHA® Collection yet, now’s the time to see what the hype is all about. Learn more at rhacollection.com. #HAFiller #FillerInjections #SettingtheNewStandard #RVNC

    • Keine alternative Textbeschreibung für dieses Bild
  • View organization page for Revance, graphic

    29,676 followers

    Award winning has a nice ring to it...Thank you ELLE Magazine for recognizing #DAXXIFY and the #RHACollection as winners of the Best Treatment category for this year's Elle Tools and Treatments Awards!  For DAXXIFY® Full Prescribing Information including Boxed Warning and Medication Guide, see https://lnkd.in/etBtYw-S     DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eye brows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face.     Call your doctor for medical advice about side effects. Intended for US audiences. 

  • View organization page for Revance, graphic

    29,676 followers

    Thank you to all who attended the 'Let’s Get Social: Social Media and Clinical Insights' education event at Revance headquarters this weekend, and thank you to Erika Barry, Libby Dysart, and Natalie Zfat for sharing your expertise! We had a great time and hope you did too! Now, who’s ready for practice integration training in August? #RevanceAesthetics #SettingtheNewStandard #RVNC Watch for Important Safety Information. For Full Prescribing Information, including Boxed Warning and Medication Guide, see https://lnkd.in/etBtYw-S DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine that is injected into muscles and used to treat cervical dystonia in adults. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, and breathing due to weakening of associated muscles can be a sign of a life-threatening condition. The most common side effects are headache, injection site pain, injection site redness, muscle weakness, and upper respiratory tract infection. Call your doctor for medical advice about side effects. Intended for US audiences.

  • View organization page for Revance, graphic

    29,676 followers

    Word is spreading about the #DAXXIFY difference in glabellar lines and the #RHACollection of fillers made for dynamic facial movement. DAXXIFY® is the latest innovation in the neurotoxin market in more than 20 years. With proprietary peptide technology, fast onset,* and long-lasting results, it’s no wonder the awards are rolling in. DAXXIFY® has been named Best for Long-Lasting Results in the Shape Skin Awards 2024, Best Game-Changing Pro Treatment in the Cosmopolitan 2024 Holy Grail Beauty Awards, and Best Treatment for Fine Lines/Wrinkles in The Zoe Report Beauty Groundbreaker Awards. The RHA® Collection includes the first and only FDA-approved fillers for dynamic areas of the face—dynamic wrinkles and folds (RHA® 2, RHA® 3, and RHA® 4), dynamic perioral lines (RHA Redensity™), and the lips (RHA® 3). RHA® 4 is now a NewBeauty 2024 award winner, named Best Filler for Nasolabial Folds, and RHA Redensity™ has been named the Most Natural Looking Treatment in the Shape Skin Awards 2024. See for yourself what the buzz is all about. Learn more about DAXXIFY® and the RHA® Collection: revanceaesthetics.com #RVNC #SettingtheNewStandard #RevanceAesthetics Swipe for Important Safety Information. For DAXXIFY® Full Prescribing Information including Boxed Warning and Medication Guide, see https://lnkd.in/etBtYw-S DAXXIFY® (daxibotulinumtoxinA-lanm) is a prescription medicine for adults to temporarily improve the look of moderate to severe frown lines between the eye brows. Ask your doctor to tell you about DAXXIFY®. DAXXIFY® may cause serious side effects hours to weeks after injection. Alert your doctor right away as difficulty swallowing, speaking, breathing, eye problems or muscle weakness can be a sign of a life-threatening condition. The most common side effects are headache, eyelid drooping, and loss of the ability to move some muscles in your face. Call your doctor for medical advice about side effects. Intended for US audiences. *Onset as early as day 1 and typically within 2 days, based on pooled patient diary data from SAKURA 1 and SAKURA 2

  • View organization page for Revance, graphic

    29,676 followers

    Revance is proud to celebrate the history, achievements, and resilience of Black Americans on Juneteenth! To honor this important day, our employee resource group ViBE hosted a Juneteenth Lunch & Learn – Building Community Through Understanding. Thank you ViBE Members Leona Bogee, Amelia Hill, MBA, PMP, and Mark Jones for hosting this very special event and a very special thank you to Revance Board Member, Olivia Ware, Chief Legal Officer, General Counsel & Corporate Secretary, Dwight Moxie, and Chief People Officer, Amie Krause, for leading our panel discussion. #Juneteenth #FreedomDay #BlackHistory #RVNC #SettingtheNewStandard

    • Keine alternative Textbeschreibung für dieses Bild
    • Keine alternative Textbeschreibung für dieses Bild
    • Keine alternative Textbeschreibung für dieses Bild
    • Keine alternative Textbeschreibung für dieses Bild
    • Keine alternative Textbeschreibung für dieses Bild
      +2

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen

Finanzierung

Revance 17 total rounds

Letzte Runde

Eigenkapital nach dem IPO

US$ 100.0M

Siehe mehr Informationen auf crunchbase